Pure Sunfarms and NOYA Bring Cookies Sun-Grown Flower to Ontario
Ryan Allway May 3rd, 2022 News, Top News Large Format 14g Bags of Cookies Sun-Grown, Whole Flower Available This Month DELTA, British Columbia, May 03, 2022 (GLOBE NEWSWIRE) — Today, Pure Sunfarms Corp. (“Pure Sunfarms”), a wholly-owned subsidiary of Village Farms International, Inc. (Nasdaq: VFF) and NOYA Cannabis Inc.... Read more
ALLIED CORP Announces Approval Of Psychoactive (THC) Quota For The Production Of Colombian THC Cannabis Flower
Ryan Allway May 3rd, 2022 News, Top News KELOWNA, British Columbia, May 03, 2022 (GLOBE NEWSWIRE) — Allied Corp. (“Allied” or the “Company”) (OTCQB: ALID) is pleased to announce the approval of its 2022 quota for the production and sale of THC cannabis flower. On April 29th, 2022 the Colombian government... Read more
Irwin Naturals to File Q4 and Full Year Results for Fiscal 2021
Ryan Allway May 3rd, 2022 News, Top News Conference Call on Tuesday, May 3, 2022 at 2:00pm EST LOS ANGELES, May 03, 2022 (GLOBE NEWSWIRE) — Irwin Naturals Inc. (CSE: IWIN) (OTC: IWINF) (FRA: 97X) (“Irwin” or the “Company”) today announced the Company will file its results for the fiscal fourth... Read more
Lowell Farms to Debut All-New Collaboration and Showcase Award-Winning Brand During Hall of Flowers
Ryan Allway May 3rd, 2022 News, Top News California cannabis leader to welcome guests into the ‘Lowell Lounge’ SALINAS, Calif., May 03, 2022 (GLOBE NEWSWIRE) — Lowell Farms Inc. (CSE:LOWL; OTCQX:LOWLF), a California-born innovator in cannabis cultivation and maker of the legendary brand Lowell Smokes, will showcase its exciting new line... Read more
Ryan Allway May 2nd, 2022 News, Top News Reduction in transaction valuation and a proposed offering of up to one million bonus shares to non-redeeming public shareholders to reduce their cost basis Convertible note of $16 million from a global institutional investor and a $50 million committed equity financing facility from an affiliate... Read more
Khiron Life Sciences Reports 2021 Fiscal Year End Results
Ryan Allway May 2nd, 2022 News, Top News 2021 total revenue increased over 60% YoY to $12.8 million compared to the previous year Corporation’s medical cannabis sales in 2021 increased to $4.6 million, representing 36% of total revenue The Corporation forecasts Q1 2022 sales revenue of ~ $4.5 million for the quarter Gross profit... Read more
Akanda Completes Acquisition of Holigen, Advancing Cannabis Leadership Position in Europe, the Middle East and Africa (EMEA)
LONDON–(BUSINESS WIRE)–International medical cannabis company Akanda Corp. (“Akanda” or the “Company”) (NASDAQ: AKAN) today announced it has closed the acquisition of Holigen Limited (“Holigen”) from The Flowr Corporation (“Flowr”) (TSXV: FLWR, OTC: FLWPF), accelerating Akanda’s seed-to-patient business model in the EMEA region, improving the Company’s ability to meet growing... Read more
Westwood Budega™️ Receives State Permit and Prepares for Opening in May
Adjacent to Beverly Hills, located at 10461 Santa Monica Blvd., ZXC11 has leased approximately 1,500 square feet in Westwood within two miles of the University of Los Angeles California campus (“UCLA”). One of the most vibrant and heavily trafficked areas of metropolitan Los Angeles, the location boasts over 161,000 daily vehicles within three blocks. This... Read more
Molecule Holdings Inc. Celebrates Spring Launch with PHRESH Summer Punch #1 Top Seller
Ryan Allway April 28th, 2022 News, Top News Ottawa, ON April 28, 2022 – Molecule Holdings Inc. (CSE: MLCL) (“Molecule” or the “Company”), a Canadian craft-focused cannabis beverage production company, is thrilled with the reception of their new beverages launched through Ontario Cannabis Stores (OCS) this spring. Ontario consumers... Read more
Skye Bioscience Engages Clinical Trial Site for Phase 1 Study in Agreement with CMAX Clinical Research
Ryan Allway April 28th, 2022 News, Top News San Diego, California, April 28, 2021 — Skye Bioscience, Inc. (OTCQB: SKYE) (“Skye” or the “Company”), a pharmaceutical company developing proprietary, synthetic cannabinoid derivatives to treat glaucoma and other diseases with significant unmet need, has retained CMAX Clinical Research (“CMAX”) to facilitate enrollment of and... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )